HomeInsightsEPS

Alembic Pharmaceuticals Ltd EPS

Alembic Pharmaceuticals Ltd EPS

stocks purchased

₹ 0.9 Cr

Volume Transacted

(Nov 8, 2024)

stocks purchased

8.2 K

Stocks Traded

(Nov 8, 2024)

Last Updated on: Nov 08, 2024

Image

Alembic Pharmaceuticals Ltd

NSE: APLLTD

EPS

₹ 32.4

Last updated on: Nov 07, 2024

Key Highlights

  • The Earning per Share of Alembic Pharmaceuticals Ltd is ₹ 32.4 as of 07 Nov 24.
  • The Earning per Share of Alembic Pharmaceuticals Ltd changed from ₹ -3.35 to ₹ 7.79 over 10 quarters. This represents a CAGR of NaN% .

Historical Earning per Share of Alembic Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Alembic Pharmaceuticals Ltd

Market Cap

21,257 Cr

EPS

32.4

P/E Ratio (TTM) *

33.4

P/B Ratio (TTM) *

4.3

Day’s High *

1093.45

Day’s Low

1041.0

DTE *

0.2

ROE *

13.2

52 Week High

1296.15

52 Week Low

710.5

ROCE *

12.8

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Alembic Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 20241081.45
06 Nov 20241139.2
05 Nov 20241126.3
04 Nov 20241124.65
01 Nov 20241121.4
31 Oct 20241128.75
30 Oct 20241083.3
29 Oct 20241061.6
28 Oct 20241074.2
25 Oct 20241068.5

SWOT Analysis Of Alembic Pharmaceuticals Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Alembic Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Alembic Pharmaceuticals Ltd

Market Value

21,257

Asset Value

3,379

5.3 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Company NameEPSMarket Cap (INR Cr.)
Alembic Pharmaceuticals Ltd3221,257
Sun Pharmaceuticals Industries Ltd464,29,841
Divis Laboratories Ltd631,58,179
Cipla Ltd571,27,063
Mankind Pharma Ltd521,09,234
Dr Reddys Laboratories Ltd631,07,398

Historical Market Cap of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Alembic Pharmaceuticals Ltd News Hub

News

Alembic Pharma gets USFDA nod for hypertension treatment drug

The said drug is therapeutically equivalent to the reference listed drug product (RLD), Di...

Read more

21 Oct 202411:23

News

Alembic Pharmaceuticals to discuss results

Alembic Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 ...

Read more

18 Oct 202417:20

News

Alembic Pharma's oncology formulations unit successfully completes USFDA inspection

Alembic Pharmaceuticals has successfully completed the United States Food and Drug Adminis...

Read more

09 Oct 202409:16

News

Alembic Pharma rises after oncology facility completes US FDA audit with 'zero' observations

The US FDA had conducted an inspection at the company's oncology (injectable and oral soli...

Read more

09 Oct 202409:21

News

Alembic Pharma gets US FDA nod for antihistamine Alcaftadine ophthalmic solution

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)...

Read more

04 Oct 202409:29

News

Alembic Pharma receives USFDA approval for Lamotrigine Extended-Release Tablets

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration...

Read more

03 Oct 202409:23

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

Feb 2023

Transcript

Nov 2022

Transcript

Aug 2022

Transcript

May 2022

Transcript

Nov 2021

Transcript

Aug 2021

Transcript

May 2021

Transcript

FAQs for EPS of Alembic Pharmaceuticals Ltd

What is the EPS of Alembic Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Alembic Pharmaceuticals Ltd is 32.4. An EPS is the amount of net income attributed to each share of a common stock.

How is Alembic Pharmaceuticals Ltd EPS calculated?

The EPS of Alembic Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Alembic Pharmaceuticals Ltd report its EPS?

Alembic Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Alembic Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Alembic Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Alembic Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Alembic Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*